Hepatic gene expression in patients with obesity‐related non‐alcoholic steatohepatitis

Abstract excerpt

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver disease. NAFLD includes a spectrum of clinicopathologic syndromes that includes non-alcoholic steatohepatitis (NASH) that has potential for progression. The pathogenesis of NASH is poorly characterized. AIM: This study was designed to identify differences in hepatic gene expression in patients with NASH and to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alcohol Consumption and Health Effects
• Share to Liver Disease Diagnosis and Treatment
• Share to Liver Diseases and Immunity